(Q50950377)

25 March 2018

title

Prognostic value of histology in patients with non-small cell lung cancer. (English)

1 reference

25 March 2018

author name string

Charloux A

1

1 reference

25 March 2018

Hedelin G

2

1 reference

25 March 2018

Dietemann A

3

1 reference

25 March 2018

Ifoundza T

4

1 reference

25 March 2018

Roeslin N

5

1 reference

25 March 2018

Pauli G

6

1 reference

25 March 2018

Quoix E

7

1 reference

25 March 2018

publication date

1 May 1997

1 reference

25 March 2018

published in

Lung Cancer

1 reference

25 March 2018

volume

17

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

123-134

1 reference

25 March 2018

Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Nonanatomic prognostic factors in carcinoma of the lung: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Alveolar carcinoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

The World Health Organization histological typing of lung tumours. Second edition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Assessment of Lung Cancer Risk Factors by Histologic Category

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Extrathoracic staging of bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

The solitary pulmonary nodule. Ten-year follow-up of veterans administration-armed forces cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Diameter, cell type, and survival in stage I primary non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Clinical Indicators of Prognosis in Unresected Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900655-7

7 January 2021

10.1016/S0169-5002(97)00655-7

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

9194032

1 reference

25 March 2018